The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone
Open accessAbstract
Lung cancer is the number one cause of cancer-related deaths in the world. Patients treated with current chemotherapies for non-small-cell lung cancers (NSCLCs) have a survival rate of ≈15% after 5 years. Novel approaches are needed to treat this disease. We show elevated NAD(P)H:quinone oxidoreductase-1 (NQO1) levels in tumors from NSCLC patients. β-Lapachone, an effective chemotherapeutic and radiosensitizing agent, selectively killed NSCLC cells that expressed high levels of NQO1. Isogenic H596 NSCLC cells that lacked or expressed NQO1 along with A549 NSCLC cells treated with or without dicoumarol, were used to elucidate the mechanism of action and optimal therapeutic window of β-lapachone. NSCLC cells were killed in an NQO1-dependent manner by β-lapachone (LD 50 , ≈4 μM) with a minimum 2-h exposure. Kinetically, β-lapachone-induced cell death was characterized by the following: ( i ) dramatic reactive oxygen species (ROS) formation, eliciting extensive DNA damage; ( ii ) hyperactivation of poly(ADP-ribose)polymerase-1 (PARP-1); ( iii ) depletion of NAD + /ATP levels; and ( iv ) proteolytic cleavage of p53/PARP-1, indicating μ-calpain activation and apoptosis. β-Lapachone-induced PARP-1 hyperactivation, nucleotide depletion, and apoptosis were blocked by 3-aminobenzamide, a PARP-1 inhibitor, and 1,2-bis(2-aminophenoxy)ethane- N , N , N′ , N′ -tetraacetic acid acetoxymethyl ester (BAPTA-AM), a Ca 2+ chelator. NQO1 − cells (H596, IMR-90) or dicoumarol-exposed NQO1 + A549 cells were resistant (LD 50 , >40 μM) to ROS formation and all cytotoxic effects of β-lapachone. Our data indicate that the most efficacious strategy using β-lapachone in chemotherapy was to deliver the drug in short pulses, greatly reducing cytotoxicity to NQO1 − “normal” cells. β-Lapachone killed cells in a tumorselective manner and is indicated for use against NQO1 + NSCLC cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Olive, P. L., Banáth, J. P., Durand, R. E., & Banath, J. P. (1990) · Radiation Research · doi:10.2307/3577587 · Cited by 1,094
Olive, P. L., Banáth, J. P., & Durand, R. E. (2012) · Radiation Research · doi:10.1667/rrav04.1 · Cited by 1,029
Multidisciplinary Management of Lung Cancer
Spira, A., & Ettinger, D. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035536 · Cited by 922
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Alkylating DNA damage stimulates a regulated form of necrotic cell death
Zong, W.-X., Ditsworth, D., Bauer, D. E., Wang, Z.-Q., & Thompson, C. B. (2004) · Genes & Development · doi:10.1101/gad.1199904 · Cited by 618
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Self-citationNAD(P)H:Quinone Oxidoreductase Activity Is the Principal Determinant of β-Lapachone Cytotoxicity
Pink, J. J., Planchon, S. M., Tagliarino, C., Varnes, M. E., Siegel, D., & Boothman, D. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5416 · Cited by 376
Self-citationNAD(P)H:Quinone Oxidoreductase 1 (NQO1, DT-Diaphorase), Functions and Pharmacogenetics
Ross, D., & Siegel, D. (2004) · Methods in Enzymology · doi:10.1016/s0076-6879(04)82008-1 · Cited by 245
Li, Y., Sun, X., LaMont, J. T., Pardee, A. B., & Li, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0538044100 · Cited by 231
Lee, Y. J., Galoforo, S. S., Berns, C. M., Chen, J. C., Davis, B. H., Sim, J. E., Corry, P. M., & Spitz, D. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5294 · Cited by 225
Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death
Ying, W., Sevigny, M. B., Chen, Y., & Swanson, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211202598 · Cited by 198
Boothman, D. A., Trask, D. K., & Pardee, A. B. (1989) · PubMed · Cited by 189
Self-citationLi, C. J., Li, Y.-Z., Pinto, A. V., & Pardee, A. B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13369 · Cited by 167
Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors.
Siegel, D. M., Franklin, W. A., & Ross, D. (1998) · PubMed · Cited by 164
Halmosi, R., Berente, Z., Ősz, E., Tóth, K., Literati-Nagy, P., & Sümegi, B. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1497 · Cited by 156
Enhancement of Solubility and Bioavailability of β-Lapachone Using Cyclodextrin Inclusion Complexes
Nasongkla, N., Wiedmann, A. F., Bruening, A. J., Beman, M., Ray, D. G., Bornmann, W. G., Boothman, D. A., & Gao, J. (2003) · Pharmaceutical Research · doi:10.1023/a:1026143519395 · Cited by 151
Self-citationCalcium Is a Key Signaling Molecule in β-Lapachone-mediated Cell Death
Tagliarino, C., Pink, J. J., Dubyak, G., Nieminen, A., & Boothman, D. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100730200 · Cited by 147
Self-citationIsolation of x-ray-inducible transcripts from radioresistant human melanoma cells.
Boothman, D. A., Meyers, M., Fukunaga, N., & Lee, S. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7200 · Cited by 134
Self-citationSrougi, M. C., Reinicke, K. E., Bey, E. A., Spitz, D. R., & Boothman, D. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603678200 · Cited by 125
Self-citationMitochondrial-derived free radicals mediate asbestos-induced alveolar epithelial cell apoptosis
Panduri, V., Weitzman, S. A., Chandel, N. S., & Kamp, D. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00371.2003 · Cited by 121
Pink, J. J., Wuerzberger‐Davis, S. M., Tagliarino, C., Planchon, S. M., Yang, X., Froelich, C. J., & Boothman, D. A. (2000) · Experimental Cell Research · doi:10.1006/excr.1999.4790 · Cited by 119
Self-citationInduction of apoptosis in MCF-7:WS8 breast cancer cells by beta-lapachone.
Wuerzberger‐Davis, S. M., Pink, J. J., Planchon, S. M., Byers, K. L., BORNMANN, W. G., & Boothman, D. A. (1998) · PubMed · Cited by 118
Self-citationDT-diaphorase and cytochrome B5 reductase in human lung and breast tumours
Marin, A., de Ceráin, A. L., Hamilton, E., Ad, L., Martinez-Peñuela, J., Idoate, M. A., & Bello, J. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.485 · Cited by 106
μ-Calpain Activation in β-Lapachone-Mediated Apoptosis
Tagliarino, C., Pink, J. J., Reinicke, K. E., Simmers, S. M., & Boothman, D. A. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.2.237 · Cited by 101
Self-citationReinicke, K. E., Bey, E. A., Srougi, M. C., Pink, J. J., Ingalls, S. T., Hoppel, C. L., Misico, R. I., Arzac, G. M., Burton, G., Bornmann, W. G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2185 · Cited by 90
Self-citationNew tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors
Srougi, M. C., Bey, E. A., Dong, Y., Reinicke, K. E., & Boothman, D. A. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9043-8 · Cited by 73
Self-citationSusceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation
Park, H. J., Ahn, K.-J., Ahn, S.-D., Choi, E., Lee, S. W., Williams, B. W., Kim, E. J., Griffin, R. J., Bey, E. A., Bornmann, W. G., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.018 · Cited by 61
Self-citationInduction of NQO1 in Cancer Cells
Begleiter, A., & Fourie, J. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82018-4 · Cited by 58
Lam, T. T. (1997) · PubMed · Cited by 54
Modulating β‐lapachone release from polymer millirods through cyclodextrin complexation
Wang, F., Blanco, E., Ai, H., Boothman, D. A., & Gao, J. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20721 · Cited by 42
Self-citation
Cited by
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
Natural products: An evolving role in future drug discovery
Mishra, B. B., & Tiwari, V. K. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.07.057 · Cited by 860
Morales, J., Li, L., Fattah, F. J., Dong, Y., Bey, E. A., Patel, M., Gao, J., & Boothman, D. A. (2014) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2013006875 · Cited by 608
Self-citation
Metadata
- Authors
- Bey, E. A., Bentle, M. S., Reinicke, K. E., Dong, Y., Yang, C.-R., Girard, L., Minna, J. D., Bornmann, W. G., Gao, J., & Boothman, D. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-07-10
- Volume
- 104
- Issue
- 28
- Pages
- 11832-11837
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2023380668
- Cited by
- 354
- References
- 34
- FWCI
- 17.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.